Saleh MN - Search Results

1

A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data.

Saleh MN, LoBuglio AF, Wheeler RH, Rogers KJ, Haynes A, Lee JY, Khazaeli MB. Saleh MN, et al. Cancer Immunol Immunother. 1990;32(3):185-90. doi: 10.1007/BF01771455. Cancer Immunol Immunother. 1990. PMID: 2126988 Free PMC article. Clinical Trial.

2

Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody.

Khazaeli MB, Saleh MN, Liu T, Kaladas PM, Gilman SC, LoBuglio AF. Khazaeli MB, et al. Among authors: saleh mn. J Clin Immunol. 1992 Mar;12(2):116-21. doi: 10.1007/BF00918141. J Clin Immunol. 1992. PMID: 1373150

3

Advances in monoclonal antibody therapy of cancer.

LoBuglio AF, Saleh MN. LoBuglio AF, et al. Among authors: saleh mn. Am J Med Sci. 1992 Sep;304(3):214-24. doi: 10.1097/00000441-199209000-00011. Am J Med Sci. 1992. PMID: 1476160 Review.

4

Monoclonal antibody therapy of cancer.

LoBuglio AF, Saleh MN. LoBuglio AF, et al. Among authors: saleh mn. Crit Rev Oncol Hematol. 1992 Nov;13(3):271-82. doi: 10.1016/1040-8428(92)90093-6. Crit Rev Oncol Hematol. 1992. PMID: 1476656 Clinical Trial. No abstract available.

5

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.

Saleh MN, Khazaeli MB, Wheeler RH, Allen L, Tilden AB, Grizzle W, Reisfeld RA, Yu AL, Gillies SD, LoBuglio AF. Saleh MN, et al. Hum Antibodies Hybridomas. 1992 Jan;3(1):19-24. Hum Antibodies Hybridomas. 1992. PMID: 1576319 Clinical Trial.

6

Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.

Saleh MN, Khazaeli MB, Wheeler RH, Dropcho E, Liu T, Urist M, Miller DM, Lawson S, Dixon P, Russell CH, et al. Saleh MN, et al. Cancer Res. 1992 Aug 15;52(16):4342-7. Cancer Res. 1992. PMID: 1643631 Clinical Trial.

7

Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.

Meredith RF, Khazaeli MB, Plott WE, Saleh MN, Liu T, Allen LF, Russell CD, Orr RA, Colcher D, Schlom J, et al. Meredith RF, et al. Among authors: saleh mn. J Nucl Med. 1992 Jan;33(1):23-9. J Nucl Med. 1992. PMID: 1730991 Free article. Clinical Trial.

8

Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.

Greiner JW, Guadagni F, Goldstein D, Borden EC, Ritts RE Jr, Witt P, LoBuglio AF, Saleh MN, Schlom J. Greiner JW, et al. Among authors: saleh mn. Cancer Res. 1991 Aug 15;51(16):4155-63. Cancer Res. 1991. PMID: 1907881 Clinical Trial.

9

Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.

Khazaeli MB, Saleh MN, Liu TP, Meredith RF, Wheeler RH, Baker TS, King D, Secher D, Allen L, Rogers K, et al. Khazaeli MB, et al. Among authors: saleh mn. Cancer Res. 1991 Oct 15;51(20):5461-6. Cancer Res. 1991. PMID: 1913665 Clinical Trial.

10

In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas.

Saleh MN, Wheeler RH, Lee JY, Khazaeli MB, Unger MW, Russell CH, LoBuglio AF. Saleh MN, et al. Clin Nucl Med. 1991 Feb;16(2):110-6. doi: 10.1097/00003072-199102000-00010. Clin Nucl Med. 1991. PMID: 2004491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters